NEW FRONTIERS IN COSMETIC MEDICINE SYMPOSIUM
November 18-19, 2017
Hasbrouck Heights, NJ
This unique one and half day meeting will deal with the latest developments in cosmetic dermatology, cosmetic medicine and anti-aging medicine. This is a highly focused forum, featuring innovative didactic sessions, geared to all physicians interested in adding and expanding these facets of their practice.
This symposium is designed for an audience of physicians, physician assistants, nurses and nurse practitioners who work under the direct supervision of dermatologists, facial plastic surgeons, oculoplastic surgeons, and plastic surgeons, and commonly assist with cosmetic surgery and medicine.
Upon completion of the educational activity, participants should be able to:
Criteria for Success
Statements of credit will be awarded based on the participant's attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.cosmeticfrontiers.com/cme. You must participate in the entire activity to receive credit. If you have questions about this CME activity, please contact AKH Inc. at firstname.lastname@example.org.
CME Credit provided by AKH Inc., Advancing Knowledge in Healthcare
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and The Dermatology Education Group. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians. AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.
|Hilary Baldwin, MD||Consultant||Biopharmx, Encore, Novan|
|Contracted Research||Allergan, Inc, Galderma Laboratories, Ortho|
|Speakers Bureau||Allergan, Inc, Bayer, Encore, Galderma Laboratories, Ortho|
|Bradley Bloom, MD||Consultant/Honoraria/Device Loan||Cutera, Inc, Sciton|
|Contracted Research||Cutera, Inc, Cynosure, Inc., Focus Medical/Lumenis|
|Diana Cohen, MD||N/A||Nothing to disclose|
|Michael Gold, MD||Advisory Board||Aerolase, Almiral, Croma, Erchonia Corporation, Inta Derm, Johnson & Johnson, Prollenium, Sente, Sinclair Pharma, Thermi Aesthetics|
|Consultant||Aerolase, Allergan, Inc, Alma Lasers, Ltd., Almiral, Anacor Pharmaceuticals, Inc., Aquavit Pharm, Bayer Healthcare Pharmaceuticals, Celgene Corporation, Clarsonic, SkinCeuticals, L’Oreal, Croma, DefanAge, DUSA Pharmaceuticals, Inc./Sun Pharma, EndyMed Medical Ltd., Erchonia Corporation, Exeltis, Galderma Laboratories, L.P., Inta Derm, Invasix Ltd., Johnson & Johnson, Lumenis Ltd., Merz Pharma, Neothetics, Novartis, Pierre Fabre, Prollenium, Promius Pharma, LLC., Sente, Sinclair Pharma, Smith & Nephew, Syneron-Candela, Suneva Medical, Inc., Thermi Aesthetics, Valeant Pharmaceuticals International, Inc., Viviscal, Zimmer|
|Stock||Aerolase, DefenAge, Intraderm, Invasix, Sente|
|David J. Goldberg, MD, JD||Consultant||RSI, Sensus Healthcare, Stratpharma, Wintech|
|Contracted Research||Allergan, Inc, Cutera, Inc, Cynosure, Inc., Galderma Laboratories, Merz Pharma, Sensus Healthcare, Sienna, Stratpharma|
|Speakers Bureau||Cutera, Inc, Lumenis, Sensus Healthcare, Stratpharma|
|Stock||Aquavit Pharmaceuticals, Inc.|
|Kseniya Golubets , MD||N/A||Nothing to disclose|
|Noelani Gonzales, MD||N/A||Nothing to disclose|
|Margarita Lolis, MD||N/A||Nothing to disclose|
|Scott Naughton||N/A||Nothing to disclose|
|Joelle Scales||N/A||Nothing to disclose|
|AKH & NFCM Staff/Planners||N/A||Nothing to disclose|
This activity is supported by educational grants from Galderma Laboratories, L.P., Merz North America, Inc.
This activity is supported by in-kind support contributions from Allergan, Inc., Galderma Laboratories, L.P., and Merz North America, Inc.
It is the policy of AKH Inc. and NFCM to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. and NFCM specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.